Down-regulation of Dicer expression in cervical cancer tissues

Hongqin Zhao1, Xiance Jin, Huafang Su

  • 1Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.

Insights

Dicer, a key microRNA enzyme, is often downregulated in cervical cancer tissues. Lower Dicer expression correlates with advanced tumor stages and metastasis, suggesting its role in oncogenesis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Dicer is essential for microRNA (miRNA) biogenesis, a process critical for gene regulation.
  • Aberrant Dicer expression is implicated in various cancers, suggesting a role in oncogenesis.

Purpose of the Study:

  • To investigate Dicer mRNA expression levels in cervical cancer tissues.
  • To determine the clinical significance of Dicer expression in cervical cancer.

Main Methods:

  • Real-time reverse transcription PCR was used to quantify Dicer mRNA levels.
  • Tissues analyzed included cervical cancer, para-cancer, and normal adjacent tissues from 31 patients.
  • Statistical analysis correlated Dicer expression with clinical characteristics.

Main Results:

  • Dicer mRNA expression was significantly decreased in 66.7% of cervical cancer tissues and 76.9% of para-cancer tissues compared to normal tissues.
  • Lower Dicer expression in tumors was associated with advanced tumor stage (p=0.03) and metastasis (p=0.01).

Conclusions:

  • Dicer expression is down-regulated in cervical cancer and surrounding tissues.
  • Reduced Dicer levels are linked to more aggressive disease characteristics, including advanced stage and metastasis.
  • Further research with larger cohorts is needed to confirm these findings and explore therapeutic implications.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K